Cargando…
Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue
Ovarian cancer has a poor prognosis due to intrinsic or acquired resistance to some cytotoxic drugs, raising the interest in new DNA-binding agents such as mithramycin analogues as potential chemotherapeutic agents in gynecological cancer. Using a genome-wide approach, we have analyzed gene expressi...
Autores principales: | Vizcaíno, Carolina, Núñez, Luz-Elena, Morís, Francisco, Portugal, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128730/ https://www.ncbi.nlm.nih.gov/pubmed/25110883 http://dx.doi.org/10.1371/journal.pone.0104687 |
Ejemplares similares
-
Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
por: Malek, Anastasia, et al.
Publicado: (2012) -
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020) -
The chromomycin CmmA acetyltransferase: a membrane‐bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin
por: García, Beatriz, et al.
Publicado: (2011) -
Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
por: Hou, Caixia, et al.
Publicado: (2016) -
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)